Peripheral nociceptors are excited by the activation of membrane receptors and ion channels. The heat-sensitive TRPV1 ion channel responds to various noxious chemical and thermal stimuli, causing pain and itch. Here, we show that TRPV1 is coexpressed with PKC␤II in a subset of mouse sensory neurons and that, in these neurons, TRPV1 binds directly to PKC␤II, leading to the activation and translocation of PKC␤II. Activated PKC␤II, in turn, significantly increases the responsiveness of TRPV1 by phosphorylating Thr705. The heat sensitivity of TRPV1 is almost eliminated by either knocking down PKC␤II or mutating Thr705; however, neither of these manipulations affects the potentiation of TRPV1 caused by the activation of PKC. PKC␤II thus acts as an auxiliary subunit of TRPV1 by forming a population-dependent TRPV1 ion channel complex controlling the sensitivity of TRPV1 and setting the threshold for pain and itch.
Introduction
The responsiveness of animals to noxious stimuli depends on the sensitivity of nociceptors in peripheral nerve endings. Many ion channels in nociceptive neurons serve as sensors or transducers conveying noxious information to the CNS. TRPV1 is such an ion channel that responds to diverse pain-producing agents, inflammatory mediators, and metabolites such as bradykinin and protons (Basbaum et al., 2009) . TRPV1 is also targeted directly by toxins derived from tarantula spider venom, producing pain and inflammation (Siemens et al., 2006) . Interestingly, excitation of TRPV1 by histamine in a subpopulation of dorsal root ganglion (DRG) neurons mediates the sensation of itch instead of pain (Shim et al., 2007) . In addition to being targeted by these painful and itching chemicals, TRPV1 is best known for its direct activation by noxious heat (Caterina et al., 1997) . The basal sensitivity of TRPV1 in response to these noxious stimuli is thus critical for the latency and intensity of elicited pain and itch; however, it is little known about how the basal sensitivity of TRPV1, and in particular its thermal sensitivity, is determined.
It is well known that different populations of TRPV1 ϩ neurons exhibit differential sensitivities to heat even though they respond similarly to the agonist capsaicin; conversely, not all capsaicin-responding neurons are heat sensitive (Kirschstein et al., 1997; Vyklický et al., 1999) . Furthermore, there are many discrepancies between heat-and capsaicin-evoked currents in DRG neurons, leading to speculation that different TRPV1 channel complexes may have been formed in different populations of neurons (Nagy and Rang, 1999b) ; however, no such TRPV1 complexes have ever been identified. Membrane lipids are negative regulators of the basal sensitivity of TRPV1 , but it is unknown whether different populations of neurons have different levels of phosphoinositide lipids giving rise to different sensitivities of TRPV1. Collectively, the mechanisms causing varied thermal sensitivity of TRPV1 are still poorly understood.
In contrast, the mechanisms underlying the modulation of TRPV1 sensitivity in disease conditions such as inflammation are relatively well understood. During inflammation, the thermal threshold of TRPV1 is reduced significantly, leading to inflammatory thermal hyperalgesia through a mechanism involving sensitization of TRPV1 via phosphorylation of the channel by activated PKA or PKC (Huang et al., 2006) . Sensitization of TRPV1 also requires the scaffolding protein AKAP79/150, which anchors both PKA and PKC adjacent to TRPV1 (Jeske et al., 2008; Schnizler et al., 2008; Jeske et al., 2009 ). However, it is unknown whether this mechanism may also determine the basal sensitivity of TRPV1.
Here, we report that the basal sensitivity of TRPV1 is determined mainly by PKC␤II, but not by PKC. TRPV1 is sufficient to activate PKC␤II through direct binding to the kinase domain of PKC␤II. Activated PKC␤II then phosphorylates TRPV1 at the residue Thr705, leading to an increased sensitivity of TRPV1. Coexpression of PKC␤II and TRPV1 was found in a subpopulation of DRG neurons, where they form a population-dependent TRPV1 ion channel complex. This population of TRPV1 neurons may represent a subset of hypersensitive nociceptive neurons.
Materials and Methods

Cell culture and transfection
HEK293 cells and HEK 293 Tet-on advanced cells (Clontech) were maintained in DMEM containing 10% FBS, 100 UI/ml ampicillin, 100 g/ml streptomycin, and 2 mM L-glutamine in a humidified incubator containing 5% CO 2 . For the culture of HEK 293 Tet-on cells, 500 g/ml G-418 (Sigma) was also included in the medium. Cells were transfected with the polyfect transfection reagent (QIAGEN), as described previously (Zhang et al., 2012) , and used for electrophysiology 2 d after transfection. For Western blotting, cells were transfected with TurboFect reagent (Fermentas) according to the manufacturer's instructions.
DRG neurons were isolated from neonatal Wistar rats (Ͻ7 d), wildtype C57BL/6 mice, and TRPV1-null mice of either sex, and cultured as described previously . Briefly, DRG were collected and dissociated with collagenase IV (Worthington). Dissociated neurons were then cultured in the DMEM containing 50 ng/ml NGF (Promega) and 1.2 g/ml cytosine-D-arabinofuranoside. in some experiments, neurons were transfected with the Amaxa rat neuron nucleofector kit using a nucleofection device according to the manufacturer's instructions.
cDNA constructs
GFP-PKC␤II was kindly provided by Dr. Yusuf Hannun (Feng et al., 1998) . PKC␤II was a kind gift from Dr. Alexandra Newton (University of California at San Diego). To induce PKC␤II expression in the Tet-On expression system, the coding cDNA for PKC␤II or its kinase domain was incorporated into the pTRE2 vector (Clontech) through BamHI and XbaI. The GST-coupled TRPV1 N-terminal and C-terminal fragments were constructed and used as described previously (Zhang et al., 2005) . The GST-coupled C1C2 domain and the kinase domain from PKC␤II were constructed by incorporating PKC␤II fragments into the GSTpcNDA3 mammalian expression vector. The human PKC␤II shRNA was constructed by ligating synthesized oligos (targeting sequence: 5Ј-GGTCATGCTTTCAGAACGAAA-3Ј) into the siRNA expression vector pGSU6-GFP (Genlantis) though BamHI and NotI according to the manufacturer's instructions. The corresponding scrambled sequence was 5Ј-ATAGGATACGGACGTCATATC-3Ј. The targeting sequence for rat PKC␤II was 5Ј-GGTACCAAGGCTCCAGAAGAA-3Ј. The human PKC shRNA was constructed similarly by targeting the following sequence: 5Ј-GGTCATGTTGGCAGAACTCAA-3Ј. The corresponding scrambled sequence was 5Ј-ATAGCCAGAACGGTTGTCTAG-3Ј. Successfully transfected cells were identified using the coexpressed gene reporter GFP from the shRNA vector. All other mutations were generated using the Site-Directed Mutagenesis Kit (Agilent) according to the manufacturer's instructions. All constructs were confirmed by DNA sequencing.
Protein biochemistry
GST pull down. The GST-coupled TRPV1 N-terminal and C-terminal fragments were expressed and purified from BL21 cells, as described previously ). Purified protein fragments were then incubated with pure PKC␤II (Merck). For pull down of TRPV1 by PKC␤II fragments, HEK293 cells expressing GST-coupled PKC␤II protein fragments and TRPV1 were solubilized in a lysis buffer containing 10 mM Tris, 1.0% NP-40, 150 mM NaCl, 1.0 mM EDTA, and 1.0 mM EGTA plus protease inhibitor mixture (Roche). GST-binding proteins were then pulled down by glutathione-agarose (Sigma), followed by extensive washing. Proteins interacting with GST-coupled protein fragments were analyzed on a 10% SDS-PAGE gel.
Immunoprecipitation. Coimmunoprecipitation was performed as described previously . TRPV1 from DRG lysates was precipitated by anti-TRPV1 antibody (Santa Cruz Biotechnology) and then isolated by protein A-agarose. To investigate the interactions between TRPVs (TRPV1, TRPV2, TRPV3, and TRPV4) and PKC␤II, HEK 293 cells transfected with cDNAs coding for TRPVs-V5 and PKC␤II were solubilized in the lysis buffer, followed by incubation with anti-V5 antibody (Invitrogen) and protein A-agarose (Santa Cruz Biotechnology). Agarose-associated proteins were then dissociated with a sample buffer and analyzed on SDS-PAGE gels.
In vitro PKC phosphorylation assay. Phosphorylation of the purified GST-coupled TRPV1 C-terminal fusion protein by PKC␤II was conducted in a 30 l of kinase buffer containing 25 mM Tris-HCl, pH 7.5, 0.5 mM DTT, 10 mM MgCl 2 , 0.6 mM CaCl 2 , 100 M ATP, and 1 g of purified GST-C-TRPV1 or GST-C-T705A TRPV1 protein fragments plus 25 ng of PKC␤II (Enzo Life Sciences). To determine whether TRPV1 enhances PKC␤II activity, PKC␤II was also precipitated by the anti-GFP antibody (Santa Cruz Biotechnology) from HEK293 cell lysate containing GFP-PKC␤II either alone or together with TRPV1 (see Fig. 4H ). Immunoprecipitated PKC␤II was washed three times with the lysis buffer and twice with the kinase buffer and then incubated with 30 l of kinase buffer in the presence of 1 g of GST-C-TRPV1 fusion protein. The reactions were incubated at 30°C for 60 min and terminated by boiling in sample buffer, followed by analysis on SDS-PAGE gels. Phosphorylation of fusion proteins was detected using the anti-phosphothreonine antibody (Cell Signaling Technology).
Western blotting. Protein samples were resolved on 10% SDS-PAGE gels and then transferred to a PVDF membrane. Blots were incubated with primary antibodies, followed by horseradish peroxidase-conjugated secondary antibodies (GE healthcare). Proteins on the blot were visualized by enhanced chemiluminescence (Pierce). The PKC␤II and PKC antibodies were obtained from Santa Cruz Biotechnology, the tubulin antibody was from Sigma, and the GST antibody was from GE Healthcare.
Immunocytochemistry
Cultured DRG neurons were fixed with 4% paraformaldehyde and then permeabilized with 0.1% Triton X-100. After blocking with 0.1% gelatin, cells were incubated with mouse anti-TRPV1 (Santa Cruz Biotechnology) and rabbit anti-PKC␤II antibodies, followed by secondary antibodies (Alexa Fluor 594 anti-mouse and Alexa Fluor 488 anti-rabbit; both from Life Technologies). Cells were mounted onto a slide for examination by confocal microscopy. The localization of PKC␤II was examined visually by two independent experimenters. A distinct, ring-like staining of PKC␤II (see Fig. 1B ) was considered to indicate localization at the plasma membrane; otherwise, localization was considered to be cytoplasmic.
Electrophysiology
Whole-cell patch clamping was performed as described previously Zhang et al., 2012) . Electrodes were fabricated from glass capillaries using a micropipette puller (Sutter Instruments). The electrodes had resistances of 2-4 M⍀ when filled with internal solution containing the following (in mM): 140 KCl, 2.0 MgCl 2 , 5.0 EGTA, 10 HEPES, pH 7.4, with KOH. Cells were perfused with a bath solution containing the following (in mM): 140 KCl, 1.0 MgCl 2 , 1.8 CaCl 2 , 10 HEPES, pH 7.4, with KOH. TRPV1 inward currents were measured at a holding potential of Ϫ60 mV. To determine temperature-induced activation of TRPV1, the temperature of the perfusion solution was controlled by a Peltier device (CV Scientific), generating a ramp of temperatures from 21°up to 48°C. The I-V relationship of TRPV1 channels was revealed using a ramp protocol starting at Ϫ120 mV, followed by a 650 ms linear ramp-up to 160 mV. To examine TRPV1 activation by depolarization, 0 mV of initial holding potential was applied followed by steps of 100 ms voltage pulses ranging from Ϫ140 mV to ϩ200 mV in 20 mV increments, with a final step to ϩ60 mV. The half-maximal activation voltage (V 1/2 ) was obtained by the fitting normalized channel conductance (G/G max )-voltage relationship to a Boltzmann equation as follows:
Series resistance was routinely Յ10.0 M⍀ and was compensated Ͼ75%. For neuronal recordings, we chose small rat DRG neurons (Ͻ25 M). All recordings were made at room temperature (24°C) unless otherwise stated with an Axopatch 200B patch clamp amplifier (Axon) associated with pClampex version 10.2 software (Molecular Devices). Signals were analog filtered using a 1 kHz low-pass Bessel filter.
Statistics
All data are presented as mean Ϯ SEM. Differences between groups were evaluated by one-way ANOVA with Bonferroni's post hoc test unless otherwise stated. Results were considered significant at p Ͻ 0.05.
Results
TRPV1 causes the translocation of PKC␤II in a subset of DRG neurons PKC comprises a family of important signaling kinases involved in many biological processes. It is mainly located in the cytoplasm. The translocation of PKC to the cell membrane is a hallmark of PKC activation and is elicited by a concerted cascade of second signaling messengers such as diacylglycerol and calcium (Parker and Murray-Rust, 2004) . We investigated the expression of PKC␤II and PKC in DRG neurons. Consistent with a previous report (Cesare et al., 1999) , PKC was mainly expressed in the cytoplasm in all DRG neurons (Fig. 1A) . Similar observations were also made for PKC␤II in a proportion of DRG neurons (38%; Fig. 1B ). However, PKC␤II was expressed on the plasma membrane in a subpopulation of small DRG neurons (17%; Fig.  1B-E) . Interestingly, this latter subpopulation of DRG neurons always coexpressed TRPV1 (Fig. 1 B, D) . In contrast, TRPV1 was not expressed in most of the neurons (87%) in which PKC␤II was localized in the cytoplasm (Fig. 1 B, D) . The membrane localization of PKC␤II is thus highly correlated with coexpression of TRPV1 in DRG neurons.
To investigate whether TRPV1 drives the translocation of PKC␤II to the cell membrane, we performed colocalization studies in neurons isolated from mice lacking the TRPV1 gene. As anticipated, the membrane expression of PKC␤II was almost absent from DRG neurons deficient in TRPV1 (Fig. 1F ) , supporting the idea that TRPV1 does indeed cause the translocation of PKC␤II in a subset of DRG neurons.
TRPV1 binds directly to PKC␤II
The close relationship between coexpression of TRPV1 and translocation of PKC␤II can also be recapitulated in an in vitro expression system. Figure 2A shows that PKC␤II was expressed in the cytoplasm of HEK293 cells in the absence of TRPV1, but was translocated to the membrane in cells coexpressing TRPV1. These data suggest that PKC␤II may bind directly to TRPV1, leading to the translocation of PKC␤II. Indeed, PKC␤II can be coprecipitated by TRPV1 from both DRG neurons and HEK293 cells expressing both proteins (Fig. 2 B, C) . Binding of PKC␤II to TRPV1 is twice as strong as both control and binding to other members of TRPV family (TRPV2, TRPV3, and TRPV4; Fig. 2C ). To determine whether the interaction between TRPV1 and PKC␤II is direct or indirect, we used the GST-coupled cytoplasmic fragments of TRPV1 to pull down purified PKC␤II. Figure  2D shows that PKC␤II binds only to the TRPV1 N terminus, not to a control GST tag or to the TRPV1 C terminus. In contrast, neither the N terminus nor the C terminus of TRPV1 bound directly to PKC in a similar experiment (Fig. 2E) . The lack of direct binding of PKC to TRPV1 is consistent with the finding that PKC requires the scaffolding protein AKAP79/150 to mediate an indirect interaction with TRPV1 . These data demonstrate that TRPV1 binds directly to PKC␤II, but not to PKC, leading to the translocation of PKC␤II.
We then investigated further which regions on PKC␤II are responsible for its binding to TRPV1. PKC␤II contains two important structural domains, the C1C2 domain and the catalytic kinase domain. Both domains are essential for the activation of PKC␤II. We constructed protein fragments for these two domains and coupled them to a GST tag for a GST pull-down assay. TRPV1 was pulled down by the kinase domain, but not by the C1C2 domain of PKC␤II nor by a control GST tag (Fig. 2F ) . Binding to the kinase domain of PKC␤II is specific to TRPV1 because none of other TRPVs (TRPV2, TRPV3, or TRPV4) was pulled down by the same domain of PKC␤II (Fig. 2G) , which is consistent with the results of the coimmunoprecipitation experiment (Fig. 2C ). These experiments demonstrate that TRPV1 binds directly to the kinase domain of PKC␤II, an event that may expose the kinase domain, leading to the translocation and thus activation of PKC␤II.
PKC␤II causes the downregulation of TRPV1 by phosphorylating the channel
We further examined the expression of TRPV1 and PKC␤II in HEK293 cells coexpressing the two proteins. Surprisingly, coexpression of PKC␤II caused the downregulation of TRPV1 (Fig.  3A) . Similar TRPV1 downregulation was also observed with PKC␣, another member of the conventional PKC family. However, other members of PKC family, such as PKC␦ or PKC, had no effect on TRPV1 expression (Fig. 3A) . Reciprocally, the downregulation of TRPV1 was accompanied by the reduced expression of PKC␣ and PKC␤II ( Fig. 3 A, B ), but no expression changes in PKC␦ or PKC were observed upon coexpression with TRPV1 ( Fig. 3 A, B) .
To monitor the downregulation of TRPV1 by PKC␤II dynamically, we incorporated PKC␤II into a pTRE2 vector containing a Tet-On promoter, the activity of which can be controlled by doxycycline (DOX). Under this Tet-On system, the expression of PKC␤II can be induced dynamically by DOX. We then coexpressed TRPV1 with PKC␤II-pTRE2 in Tet-On HEK293 cells. Fig. 3C shows that the expression of PKC␤II is gradually increased after the addition of DOX and, correspondingly, the expression of TRPV1 begins to fall after 8 h. The downregulation of TRPV1 becomes prominent after 24 h of DOX induction. In all of following functional studies, we used 8 h of PKC␤II induction to avoid excessive downregulation of TRPV1 protein.
We next examined the mechanisms causing the downregulation of TRPV1 by PKC␤II. The downregulation of TRPV1 is not caused by the actions of known proteases such as caspase, calpain, and metalloprotease ( Fig. 3D ) nor by a nonspecific interference with TRPV1 transcription due to PKC␤II coexpression (data not shown). It is also not a result of proteolysis in proteasomes or lysosomes, two principal proteolytic systems in cells, because inhibitors for these enzymes and organelles did not prevent the downregulation of TRPV1 caused by PKC␤II (Fig. 3 D, E, and data not shown). The downregulation of TRPV1 and PKC␤II was, however, prevented by either the general TRP channel pore blocker ruthenium red (RR) or, even more potently, by the specific TRPV1 blocker N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC; Fig. 3 F, G), On the right is a merged image. Scale bars, 10 m. B, PKC␤II was coprecipitated by TRPV1 in DRG neurons. TRPV1 was precipitated by anti-TRPV1 or a control IgG followed by the detection with anti-PKC␤II (top blot). The blot was stripped and reprobed with anti-TRPV1 antibody (bottom blot). Molecular weight is shown on the right and is the same in all other blots. C, TRPV proteins were precipitated by anti-V5 from HEK293 cell lysates expressing PKC␤II together with different TRPV channels (all tagged with V5) as indicated, and associated PKC␤II detected by anti-PKC␤II antibody (top blot). The same blot was stripped and reprobed for different TRPV channels by anti-V5 antibody (middle blot). The bottom blot shows the expression of PKC␤II in total cell lysates (TCL) from all groups. Note that TRPV2, TRPV3, and TRPV4 have the same nonspecific background bindings to PKC␤II as observed in control (lane 1), whereas the binding to TRPV1 is twice as high as in the other groups. PKC␤II binding was normalized to the corresponding total expression of PKC␤II, giving rise to the following relative amount of PKC␤II binding: 0.45 for control, 1.04 for TRPV1, 0.49 for TRPV2, 0.48 for TRPV3, and 0.55 for TRPV4. D, PKC␤II binds to the TRPV1 N terminus. GST-coupled TRPV1 N-terminal and C-terminal fragments were purified and incubated with purified PKC␤II. Bound PKC␤II was detected (top blot). The blot was stripped and reprobed with anti-GST to show equal levels of TRPV1 fragments (bottom blot). E, PKC does not bind directly to TRPV1. Experiments were performed as in D except that HEK293 cell lysate expressing PKC was included for the binding assay. F, TRPV1 binds to the kinase domain (KD) from PKC␤II. The GST-coupled C1C2 domain (1ϳ340) and the KD domain (341ϳ73) from PKC␤II were incubated with cell lysate expressing TRPV1. Associated TRPV1 was detected with anti-V5 antibody (top blot). The blot was stripped and reprobed with anti-GST to show similar expression of all GST fragments. G, GST-coupled kinase domain of PKC␤II binds to TRPV1, but not to TRPV2, TRPV3, or TRPV4 (all tagged with V5) in a similar GST pull-down assay as in F. All blots were repeated at least three times, with similar results.
suggesting that enhanced constitutive activity of the TRPV1 channel itself caused by PKC␤II is the main cause of protein downregulation. Consistent with this idea, the expression of TRPV1 F641L, a channel pore mutant endowing channels with high constitutive basal activity (Myers et al., 2008; Myers et al., 2008) , was barely detected, but the expression of this mutant was increased dramatically after blocking channels with RR (Fig. 3H ) . These highly active TRPV1 channels cause steady rises in intracellular calcium, leading to a cytotoxic effect (Myers et al., 2008) , which may explain the downregulation of TRPV1.
We then investigated how the binding of PKC␤II enhanced the basal activity of TRPV1. This effect could be achieved through either direct physical binding of PKC␤II leading to conformational changes in TRPV1 or enhanced catalytic enzyme activity of PKC␤II or both. To discriminate between these possibilities, we constructed two kinase-inactive PKC␤II mutants by mutating two residues (K371 and T500) on PKC␤II that are essential for catalytic activity. The downregulation of TRPV1 was abolished by both kinase-dead PKC␤II mutations (Fig. 4A) despite the fact that both mutants still bound to TRPV1 (data not shown). Furthermore, coexpression of the kinase domain of PKC␤II, an identified TRPV1-binding region, was not sufficient to cause the downregulation of TRPV1 (Fig. 4B) . These results suggest that increased catalytic activity of PKC␤II as a result of binding, not the direct physical binding per se, is mainly responsible for the enhanced function of TRPV1 and consequent downregulation of the channel, presumably through a phosphorylation-dependent mechanism.
Phosphorylation of TRPV1 by PKC is a major mechanism underlying the sensitization of TRPV1 and consequent inflammatory hyperalgesia (Cesare et al., 1999; . Two PKC phosphorylation sites, S502 and S801, have been identified as key residues for the sensitization of TRPV1 (Numazaki et al., 2002; Bhave et al., 2003; . However, mutating these two PKC phosphorylation sites did not prevent the downregulation of TRPV1 elicited by PKC␤II (Fig. 4C) . Instead, the downregulation of the S502A/S801A TRPV1 mutant was prevented by RR, similar to wild-type TRPV1 (Figs. 3F, 4D ). These results suggest that there are other, as yet unidentified PKC␤II phosphorylation sites on TRPV1 that are essential for enhanced constitutive activity of TRPV1 channels. Transfected cells were pretreated with Z-VAD (50 M; to inhibit caspase), calpeptin (5 M; to inhibit calpain), phenanthroline (Phe, 2 mM; to inhibit metallo-protease), MG132 (1 M), and lactacystin (5 M; to inhibit proteasome) for 20 h before solubilization. TRPV1 was detected by anti-V5 (top blot) followed by stripping and reprobing with antitubulin (bottom blot). F, Downregulation of TRPV1 by PKC␤II was prevented by TRPV1 blockers. Tet-On HEK-293 cells were cotransfected with TRPV1-V5 and PKC␤II-pTRE2. PKC␤II was induced 24 h after transfection for an additional 24 h with (ϩ) or without (Ϫ) ruthenium red RR (10 M) or BCTC (10 M), as indicated. The blot was probed for TRPV1 with anti-V5 (top blot), followed by stripping and reprobing with anti-PKC␤II. The blot was then further stripped and reprobed with antitubulin to show equal sample loading in all cases (bottom blot). G, Downregulation of PKC␤II by TRPV1 was prevented by RR. HEK 293 cells expressing TRPV1-V5 and PKC␤II were treated with RR (10 M) as indicated. The top blot shows the detection of PKC␤II. The blot was stripped and reprobed with antitubulin (bottom blot). H, TRPV1 F641L protein expressed from HEK293 cells was probed with anti-V5 (top blot), followed by stripping and reprobing with antitubulin (bottom blot). All blots were repeated at least three times, with similar results. Molecular weights are shown on the right for all blots.
Several serine and threonine residues on TRPV1, apart from S502 and S801, have been identified as PKC phosphorylation sites in vitro and most of these have no assigned functions (Bhave et al., 2003) . We therefore mutated all other potential PKC phosphorylation sites and investigated whether the downregulation of TRPV1 caused by enhanced activity of channels evoked by PKC␤II could be prevented. We found that the downregulation of TRPV1 was reduced dramatically by mutating Thr705, but not by mutating other potential PKC phosphorylation sites (Fig.  4 E, F ) , suggesting that Thr705 on TRPV1 is a functionally relevant PKC␤II phosphorylation site. To determine whether PKC␤II phosphorylates Thr705 directly, we performed an in vitro PKC phosphorylation assay using the GST-coupled TRPV1 C-terminal fragment and the T705A C-terminal fusion protein. Figure 4G shows that PKC␤II did not cause threonine phosphorylation of the control GST protein, but increased threonine phosphorylation of the GST-coupled TRPV1 C terminus dramatically. The increased threonine phosphorylation was substantially reduced by mutating Thr705, showing that Thr705 is indeed a major PKC␤II phosphorylation site. . E, Downregulation of TRPV1 by PKC␤II was prevented by mutating T705. Tet-On HEK293 cells were transfected with PKC␤II-pTRE2, along with different TRPV1 mutants, as indicated. PKC␤II expression was induced for 24 h with DOX. TRPV1 (top blot) and PKC␤II (middle blot) were detected by anti-V5 and anti-PKC␤II, respectively. Blots were stripped and reprobed with antitubulin (bottom blot). F, Quantification of downregulation of TRPV1 mutants by PKC␤II in at least two experiments similar to those in E. All error bars indicate mean Ϯ SEM. NS, Not significant. ***p Ͻ 0.001 compared with wild-type (WT) TRPV1. G, H, In vitro phosphorylation of purified GST-coupled TRPV1 C-terminal fragment and the T705A mutant (as indicated) by purified PKC␤II (G) or immunoprecipitated PKC␤II (H ). Protein phosphorylation was detected by anti-phosphothreonine antibody (top blot). The bottom blot is a Coomassie blue stain of corresponding purified proteins. All blots were repeated at least three times, with similar results. Molecular weights are shown on the right for all blots.
PKC␤II enhances TRPV1 activity by phosphorylating Thr705. Our evidence also suggests that the enzyme activity of PKC␤II is stimulated simply by a direct physical binding of TRPV1 without the need for additional signaling. To test this idea, PKC␤II was immunoprecipitated from cell lysates containing PKC␤II either alone or together with TRPV1 to perform an in vitro immunoprecipitation kinase assay. As expected, the presence of TRPV1 increased threonine phosphorylation of the TRPV1 C terminus significantly (Fig. 4H ) , demonstrating that TRPV1 binding facilitates the activation of PKC␤II. Together, these results demonstrate that activated PKC␤II, as a result of direct binding of TRPV1 to its kinase domain, downregulates TRPV1 channels by enhancing the basal constitutive activity of TRPV1 through phosphorylation of T705. This residue may therefore have a previously unrecognized role in tuning the activity of TRPV1 channels.
Sensitivity of TRPV1 channels is enhanced by PKC␤II, but not by PKC
We designed shRNA constructs to knock down the expression of PKC␤ and PKC selectively. Both constructs potently reduced the expression of PKC␤ and PKC, respectively, in HEK293 cells, whereas corresponding scrambled shRNAs had no effect (Fig.  5A) . To determine the effect of PKC␤II on the function of TRPV1 directly, we measured inward currents carried by TRPV1 as a function of different concentrations of capsaicin. The sensitivity of TRPV1 to capsaicin was markedly increased after the induction of PKC␤II for 8 h by DOX, resulting in a negative shift of the dose-response curve (Fig. 5B) . This occurred despite the fact that a moderate downregulation of TRPV1 was induced at this time point, showing that functional enhancement elicited by PKC␤II overrides PKC␤II-induced TRPV1 downregulation. The increased sensitivity of TRPV1 was, however, abolished by inducing the catalytically inactive PKC␤II mutant K371R (Fig. 5B) , which also abolished the downregulation of TRPV1 (Fig. 4A) . Conversely, knocking down endogenous PKC␤II reduced the sensitivity of TRPV1 dramatically, yielding a positive shift of the curve (Fig. 5B) . A similar reduction in the sensitivity of TRPV1 was also observed with the PKC␤II phosphorylation site-ablated TRPV1 mutant T705A (Fig. 5C) . Importantly, the T705A mutant abolished PKC␤II-induced enhancement of the sensitivity of TRPV1 to capsaicin (Fig. 5C ). These data show that the phosphorylation of TRPV1 by catalytically activated PKC␤II underlies increases in the sensitivity of TRPV1. To determine the effect of PKC␤II on the gating of TRPV1 by voltage, we monitored voltage-dependent currents mediated by TRPV1. The outward currents activated by depolarization were increased by induction of wild-type PKC␤II, but not by induction of the enzyme- Figure 5 . PKC␤II increases the sensitivity of TRPV1 through a phosphorylation-dependent mechanism. A, Knock down of PKC␤II and PKC by shRNAs. HEK-293 cells were transfected with scrambled or PKC␤II shRNA (top two blots) or PKC shRNA (bottom two blots), as indicated. PKC␤II and PKC were detected with anti-PKC␤II and anti-PKC, respectively. Blots were stripped and reprobed with antitubulin to show equal loading in all groups. B, Normalized whole-cell inward currents as a function of different capsaicin concentrations in Tet-On HEK293 cells. Shown are the control dose-response curve (ࡗ), EC 50 ϭ 84.51 nM; PKC␤II induction for 8 h with DOX (OE), EC 50 ϭ 38.15 nM; cotransfection with PKC␤II shRNA (), EC 50 ϭ 155.01 nM; and cotransfection with PKC␤II K371R with DOX induction (Ⅺ), EC 50 ϭ 92.56 nM. PKC␤II expression was induced by DOX for 8 h. All curves fitted with the Hill equation with a Hill coefficient of 1.5. C, Increased sensitivity of TRPV1 to capsaicin induced by PKC␤II was abolished by mutating T705. Shown are the wild-type (WT) TRPV1 dose-response curve (ࡗ), EC 50 ϭ 84.51 nM; the T705A TRPV1 dose-response curve (), EC 50 ϭ 201.2 nM; and the T705A TRPV1 dose-response curve induced with DOX for PKC␤II expression (OE), EC 50 ϭ 171.3 nM. D, TRPV1 currents evoked by a voltage ramp (from Ϫ120 mV to ϩ160 mV, 650 ms) were increased by PKC␤II induction with DOX (blue curve), but inhibited by PKC␤II shRNA (red curve). DOX-induced increases in TRPV1 currents were abolished by PKC␤II K371R (pink curve). All I-V curves are averages of 16ϳ22 recordings. E, PKC does not affect the sensitivity of TRPV1 to capsaicin. Normalized whole-cell inward currents plotted against different concentrations of capsaicin as in B. Control curve (E), EC 50 ϭ 86.94 nM; cotransfection with PKC (OE), EC 50 ϭ 79.46 nM; and cotransfection with PKC shRNA (), EC 50 ϭ 93.43 nM. The Hill coefficient is 1.5. F, TRPV1 currents evoked by a voltage ramp (from Ϫ120 mV to ϩ160 mV, 650 ms) were reduced by mutating T705 (red curve), but not by mutating two PKC phosphorylation sites S502A/S801A (DM TRPV1; pink curve) nor by coexpression with PKC (blue curve). All I-V curves are averages of 16ϳ29 recordings.
activity-deficient PKC mutant K371R (Fig. 5D ). As expected, depolarization-induced currents were reduced robustly by either knocking down PKC␤II (Fig. 5D ) or mutating the PKC␤II phosphorylation site T705 (Fig. 5F ). These data show that phosphorylation of TRPV1 at T705 by PKC␤II is critical for the gating of TRPV1 by both capsaicin and voltage.
PKC is another PKC isoform involved in the potentiation of TRPV1 after activation by inflammatory mediators such as bradykinin (Cesare et al., 1999) . Surprisingly, neither overexpression nor downregulation of PKC had any effect on the sensitivity of TRPV1 (Fig. 5E) . Furthermore, no effect on TRPV1 outward currents activated by depolarization was observed after overexpression of PKC, and the PKC phosphorylation-siteablated TRPV1 mutant (S502A/S801A) showed similar voltagedependent outward currents as wild-type TRPV1 (Fig. 5F ). These findings suggest that the basal sensitivity of TRPV1 is not determined by PKC and that PKC is mainly in an inactive state under basal condition, so it cannot regulate TRPV1 until activation by additional signaling, such as from G␣ q -protein-coupled receptors.
PKC␤II determines the heat sensitivity of TRPV1
We next measured the heat activation of TRPV1 by exposing cells to a temperature ramp from 22°C up to 48°C in Tet-On HEK293 cells expressing TRPV1. TRPV1 was typically activated at ϳ40.5°C in these cells (Fig. 6 A, B,E) . The induction of PKC␤II with DOX significantly reduced the activation threshold of TRPV1 to 36.8°C (Fig. 6C,E) , equivalent to the effect of a TRPV1 deletion mutant in which a proposed PIP 2 -binding region (777ϳ820) in the C terminus has been removed, thus rendering the channel hyper-heat sensitive (Prescott and Julius, 2003; Fig. 6F ) . The activation threshold for heat was further significantly reduced in the deletion mutant after PKC␤II induction (Fig. 6F ) , suggesting a nonoverlapping mechanism used by PKC␤II and the TRPV1 deletion mutant for enhancing the heat sensitivity of TRPV1. Concomitantly, the peak heat currents were also significantly larger after PKC␤II induction (Fig. 6C,F ) . Remarkably, TRPV1 was almost heat insensitive after knocking down endogenous PKC␤II and only a small, nonspecific membrane current was observed (Fig. 6 D, E) . The lack of heat-induced responses is not due to the absence of function of TRPV1, because a subsaturating concentration of capsaicin (1 M) still induced a similar inward current as that in the control condition (Fig. 6D) . In contrast, no effect was observed on either heat thresholds or peak heat currents by overexpression of PKC or by knocking down endogenous PKC (Fig. 6F ) . The N-terminal proximal domain of TRPV1 has been implicated as a thermal sensor of TRPV1 channels (Yao et al., 2011) . Therefore, it was interesting to deter- mine whether PKC␤II may have caused changes in the thermal sensitivity of TRPV1 through a direct physical binding to the thermal sensor. Figure 6G shows that the heat activation threshold for TRPV1 was not significantly reduced after inducing the catalytically inactive PKC␤II mutants (K371R and T500V), although there were small but significant increases in the peak heat currents. The small enhancement in peak heat currents may be caused by the direct physical binding of PKC␤II to TRPV1. Collectively, these data suggest that the catalytic enzyme activity of PKC␤II, but not PKC, is the main cause of enhanced heat responses of TRPV1, presumably through a phosphorylation-dependent mechanism, and that the direct physical binding of PKC␤II has only a minor role in regulating the heat sensitivity of TRPV1.
We have identified T705 on TRPV1 as a key PKC␤II phosphorylation site. We next determined the heat sensitivity of the T705A TRPV1 mutant. Figure 7A shows that a similar heat ramp induced a much smaller current in T705A TRPV1 compared with wild-type TRPV1, with a significantly higher activation threshold. However, the peak current elicited by a submaximal concentration of capsaicin (1 M) in the T705A mutant was similar to that in wild-type TRPV1 (Fig. 7A) . The T705A mutant also abolished PKC␤II-induced enhancement of the activation of TRPV1 by heat (Fig. 7B) . In contrast, the PKC phosphorylation-siteablated mutant did not abolish the reduction in the heat threshold of TRPV1 induced by PKC␤II (Fig. 6G) , suggesting that T705 is a key residue in regulating the heat sensitivity of TRPV1.
We then examined the mechanisms causing T705A TRPV1 to be less responsive to heat. The activation of TRPV1 by heat was suggested to be caused by the shift in the transmembrane voltage toward a physiological membrane potential (Voets et al., 2004) . As reported before (Voets et al., 2004; Zhang et al., 2008) , wildtype TRPV1 showed strong voltage dependence after steps of depolarization, but similar voltage steps induced much smaller outward currents with T705A TRPV1 (Fig. 7C) , causing a positive shift in voltage-dependent activation curve and a much higher V 1/2 (Fig. 7 D, E) .
Together, these results suggest that the heat sensitivity of TRPV1 is critically dependent on PKC␤II, which acts by phosphorylating T705. This residue thus has a pivotal role in determining the sensitivity of TRPV1 elicited by thermal and chemical stimuli.
PKC␤II is not involved in the potentiation of TRPV1 evoked by the activation of a G␣ q -protein-coupled receptor
Because the basal sensitivity of TRPV1 is determined by PKC␤II, we investigated whether PKC␤II was also involved in the sensitization of TRPV1 induced by bradykinin (BK). BK binds to the BK B2 receptor (B2R), leading to the translocation and activation of PKC, which then phosphorylates TRPV1 at two main residues, S502 and S801, leading to the sensitization of TRPV1 . As shown previously , BK induced a potent sensitization of TRPV1 in HEK293 cells expressing TRPV1 and B2R (Fig. 8A) . The sensitization of TRPV1 evoked by BK was completely abolished by knocking down PKC (Fig.  8 B, D) , confirming the critical role of PKC in this process. However, downregulating PKC␤II had no effect on the BK-induced sensitization of TRPV1 currents elicited by capsaicin (Fig. 8C,D) . Moreover, the BK-induced sensitization of TRPV1 was not attenuated in the PKC␤II phosphorylation-site-ablated TRPV1 mutant T705A (Fig. 8 E, F ) , which, however, did abolish enhanced sensitivities of TRPV1 caused by PKC␤II. These data indicate that PKC, but not PKC␤II, is critical for the potentiation of TRPV1 caused by the activation of G␣ q protein-coupled receptor, but PKC is not involved in regulating the basal sensitivity of the channel.
PKC␤II is required for the responsiveness of TRPV1 in DRG neurons
We next analyzed heat responses in cultured rat DRG neurons. A temperature ramp up to 48°C was used to activate low-threshold, heat-sensitive neurons, most of which are capsaicin sensitive and thus are mainly mediated by TRPV1. Conversely, another population of high-threshold heat-sensitive neurons (Ͼ50°C) are normally capsaicin insensitive and will not be activated by the temperature ramp used (Nagy and Rang, 1999a; Caterina et al., 2000) . Of 38 recorded neurons, 13 neurons (34.2%) were heat sensitive and also activated by capsaicin, thus expressing TRPV1. These TRPV1
ϩ neurons had a typical heat activation threshold of 42.4°C (Fig. 9A) . The proportion of heat-sensitive neurons was significantly increased after expression of PKC␤II in the DRG neurons (0.01 Ͻ p Ͻ 0001, 2 test). In this case, 28 of 42 recorded neurons (66.7%) were heat sensitive and 27 of these heat-sensitive neurons were responsive to capsaicin, with a significantly lower thermal threshold of 39.7°C and much bigger peak heat currents (Fig.  9 A, B) . We then expressed PKC␤ shRNA in the neurons, resulting in pronounced reductions in the expression of PKC␤II (Fig. 9C) . Interestingly, a significantly lower percentage of neurons (12.8%, 5 of 39, p Ͻ 0.05, 2 test) were responsive to heat in neurons transfected with PKC␤ shRNA. All five of these neurons were also capsaicin sensitive and had a significantly higher heat threshold (44.9°C) and much smaller peak heat currents (Fig. 9 A, B) . We further compared the peak current amplitudes elicited by capsaicin (1 M). Transfection of neurons with PKC␤II, but not PKC, increased capsaicin-evoked currents robustly (Fig. 9 D, E) . Conversely, knocking down PKC␤II reduced dramatically TRPV1 currents activated by capsaicin (Fig. 9 D, E) . It should be noted that native TRPV1 in DRG neurons displays a much lower sensitivity to capsaicin than that in transfected HEK293 cells (Kim et al., 2006) . Therefore, 1 M (i.e., submaximal) capsaicin can produce significant differences in TRPV1 peak currents in DRG neurons (Fig. 9 D, E) , but not in transfected HEK 293 cells (Fig.  6 A, C,D) . These results demonstrate that the heat sensitivity and responsiveness of TRPV1 depends critically on the coexpression of PKC␤II in DRG neurons.
Discussion
The sensitivity of peripheral nociceptors is fundamental to the ability to elicit pain. The expression of TRPV1 channels is a molecular signature marking nociceptive neurons. TRPV1 itself can be targeted directly and excited by a variety of chemical and thermal stimuli producing pain and itch. Therefore, understanding the mechanisms for determining the sensitivity of TRPV1 is critical for understanding these TRPV1-channel-mediated conditions. In the present study, we report that the sensitivity of TRPV1 channels is determined by PKC␤II. TRPV1 binds directly to PKC␤II and subsequently activates PKC␤II. Activated PKC␤II then enhances the responsiveness of TRPV1 to thermal and chemical stimuli through a phosphorylation-dependent mechanism. Remarkably, TRPV1 is barely heat sensitive in the absence of PKC␤II or after ablation of a PKC␤II phosphorylation site on the channel. Furthermore, expression of PKC␤II increased the proportion of heat-sensitive neurons and capsaicin-induced responses and knocking down PKC␤II reduced the percentage of neurons responding to heat and capsaicin. PKC␤II is thus an essential accessory protein for the gating of TRPV1, not only by chemical agonists, but also, importantly, by heat. This mechanism may underlie the varied thermal sensitivities of TRPV1 channels expressed in different populations of DRG neurons and in different systems in which there are different levels of PKC␤II expression.
We have identified previously a TRPV1 signaling complex formed between TRPV1 and the scaffolding protein AKAP79/ 150, which then anchors PKA, PP2B, and PKC . This signaling complex is normally inactive and becomes active only when anchored PKC becomes activated, for example, as a result of stimulation of G-protein-coupled receptors during inflammation and tissue injury. Therefore, the AKAP79/150-TRPV1 complex is mainly involved in the enhancement of heat pain (heat hyperalgesia). In the present study, TRPV1 was found to bind directly to PKC␤II, but not to PKC, forming a different local complex in a subpopulation of DRG neurons. This complex, however, was constitutively active and thus was mainly involved in regulating the basal sensitivity of TRPV1 (Fig. 9F ) . Increased sensitivity of TRPV1, determined by PKC␤II, will therefore make nociceptive neurons more sensitive to pain and itch-producing chemicals and toxins.
PKC is a primary PKC isoform in the TRPV1-AKAP79 complex involved in heat hyperalgesia. It acts by phosphorylating two functional sites, S502 and S801, on TRPV1. PKC␤II enhances the sensitivity of TRPV1 by phosphorylating a distinct residue (T705) on TRPV1 (Fig. 9F ) . The sensitization of TRPV1 induced by BK was abolished by either knocking down PKC or by mutating two PKC phosphorylation sites; however, neither of these manipulations had any effect on the sensitivity of TRPV1 (i.e., no changes in the activation by capsaicin, voltage, and temperature).
Conversely, the sensitivity of TRPV1 was reduced substantially by either downregulating PKC␤II or ablating the PKC␤II phosphorylation site, neither of which had any effect on the sensitization of TRPV1 induced by BK (Fig. 9F ). These studies demonstrate clearly that the sensitivity of TRPV1, determined by the phosphorylation of T705, and the potentiation of TRPV1, determined by the phosphorylation of S502 and S801, are two separate processes involving different mechanisms. It is likely that the thermal threshold of TRPV1 will be reduced to an even lower level by activated PKC after inflammation in a subset of PKC␤II-expressing neurons in which the basal thermal threshold is already very low. Therefore, two different PKC isoforms act in concert to regulate different aspects of pain mediated by TRPV1.
In addition to enhancing the sensitivity of TRPV1, constitutively activated PKC␤II, as a result of physical binding of TRPV1, may also target other ion channels and/or signaling messengers such as voltage-gated sodium and potassium channels, the activities of which are also regulated by PKC-mediated phosphorylation (Li et al., 1993; Enyedi and Czirjak, 2010) . The regulation of these ion channels by PKC may further facilitate the transduction of pain and/or itch. Therefore, a subpopulation of DRG neurons expressing TRPV1-PKC␤II complexes may represent a population of hypersensitive nociceptive neurons that have a more prominent role in thermal hyperalgesia and pain.
In many cases, ion channels are expressed as part of a specific protein complex containing auxiliary proteins, which strongly influence the activation, inactivation, and modulation of the channels (Isom et al., 1994) . These ion channel complexes diversify the function of ion channels, allowing ion channels to per- PKC␤II binds directly to the N terminus of TRPV1, leading to the activation of PKC␤II, which then phosphorylates T705 (shown by a star) in the C terminus of TRPV1. Phosphorylation at this residue enhances the excitability of TRPV1 channels. In contrast, PKC interacts with TRPV1 indirectly through the scaffolding protein AKAP79, which binds to TRPV1 C terminus . PKC is in an inactive state within this complex and can only be activated by additional signaling such as via activation of the G␣ q -coupled receptor B2R. Activated PKC phosphorylates two residues at S502/S801, leading to the potentiation of TRPV1.
form appropriate functions in different cells and systems. In the present study, we discovered that the function of TRPV1 channels was contingent on coexpression of PKC␤II, which binds constitutively to the channel. Therefore, PKC␤II acts as an auxiliary subunit of TRPV1, controlling its sensitivity. The N terminus of TRPV1 contains several important structural domains, including the ankyrin repeat domain and the membrane proximal domain. In particular, the membrane proximal domain in the N terminus has been implicated as a thermal sensor of TRPV1 (Yao et al., 2011) . It is thus tempting to assume that PKC␤II might modulate TRPV1 through a physical interaction with these structural domains. However, the bound PKC␤II modulates TRPV1 function mainly through induced catalytic enzyme activity as a result of binding; direct physical binding per se plays only a minor role, in contrast to many other ion channel complexes in which auxiliary subunits influence the function of channels through direct physical binding. This model of modulation is very special, because PKC␤II and TRPV1 are mutually activated simply through a process of physical binding.
This study also raises the question of how the phosphorylation of TRPV1 by PKC␤II affects the gating process of the channel. It is generally believed that temperature, voltage, and capsaicin open TRPV1 by acting on distinct structural modules (sensors), which then couple allosterically to a gating pathway on the channel (Latorre et al., 2007) . In support of this idea, a tyrosine residue in the second transmembrane domain is specifically required for capsaicin gating, but does not affect either voltage or temperature gating (Jordt and Julius, 2002) . The outer pore region of TRPV1 was suggested to act as a thermal sensor because mutations in this region specifically impair heat activation without grossly affecting either capsaicin-or voltage-induced activation of TRPV1 (Grandl et al., 2010; . However, several other modular domains have also been implicated as thermal sensors, including the N-terminal proximal domain (Yao et al., 2011 ) and the C-terminal domain (Brauchi et al., 2007) . It is unclear whether these domains serve as thermal sensors or function as allosteric couplers between temperature sensing and gate opening. In the present study, we observed that the phosphorylation of TRPV1 at T705 by PKC␤II was critical for the activation of TRPV1 by heat, as well as by capsaicin and voltage. T705 is located in the TRP domain in the C terminus of TRPV1. The recently resolved structure of TRPV1 revealed significant contacts between the TRP domain and the pre-S1 helix, a region analogous to the N-terminal proximal domain, suggesting that these contacts are important for allosteric coupling between channel domains (Liao et al., 2013) . It is likely that phosphorylation of TRPV1 by PKC␤II at T705 in the TRP domain may influence these contacts, resulting in enhanced gating. Collectively, then, the Thr705 residue has a key role in the gating of TRPV1.
Our study demonstrates that the sensitivity of TRPV1, in particular to temperature, requires the presence of PKC␤II and phosphorylation at T705. The phosphorylation by PKC␤II is thus a required precondition for driving TRPV1 channels into an optimal state for activation, even though TRPV1 channels are intrinsically heat sensitive. We emphasize, then, that the thermosensor is not always a single molecule, but rather acts as a molecular complex. Consistent with this idea, our previous study also identified a cold complex consisting of the cold-sensitive TRPM8 channel and the G␣ q protein, allowing efficient and rapid inactivation of TRPM8 channels during inflammation (Zhang et al., 2012; Li and Zhang, 2013) .
Sensory neurons are highly heterogeneous in nature, enabling them to respond appropriately to a diversity of environmental and endogenous stimuli with different qualities and intensities. Ion channel-protein complexes have emerged as an elegant mechanism allowing for ion channels in different population of neurons to react differentially to even subtle changes in intensity. A subset of hyper-constitutively sensitive sensory DRG neurons expressing TRPV1-PKC␤II complexes may be attractive targets for developing novel therapies against pain and itch.
